Connection
Nicole Massoll to Epigenesis, Genetic
This is a "connection" page, showing publications Nicole Massoll has written about Epigenesis, Genetic.
|
|
Connection Strength |
|
 |
|
 |
|
0.059 |
|
|
|
-
Ai L, Kim WJ, Demircan B, Dyer LM, Bray KJ, Skehan RR, Massoll NA, Brown KD. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis. 2008 Mar; 29(3):510-8.
Score: 0.059